Taiho Pharma Licenses PI3Kα Inhibitor Risovalisib to Haihe Biopharma
Taiho Pharma and Haihe Biopharma Form Exclusive Japanese Partnership for PI3Kα Inhibitor Risovalisib Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Haihe Biopharma Co., Ltd. (“Haihe”) today announced the signing of an…
Veradermics Raises $150M Series C for Hair Regrowth Pill
Veradermics Secures $150M Series C to Advance Oral Hair Regrowth Therapy Connecticut-based biotech Veradermics has raised $150 million in an oversubscribed Series C funding round to advance its oral hair…
Sanofi, EVOQ Partner in $500M Autoimmune Deal
Sanofi and EVOQ Therapeutics Form $500 Million Partnership to Advance Autoimmune Therapies Sanofi, a global pharmaceutical giant, has entered into a strategic collaboration with EVOQ Therapeutics, a clinical-stage biotechnology company,…
FDA Orphan Drug Chief Departs Amid IRA Exemption Launch
FDA’s Orphan Drug Leadership Shifts Amid Policy Changes and Department-Wide Shakeups Sandra Retzky, formerly the top orphan drug regulator at the FDA, is no longer serving as director of the…
Bayer Foundation Honors Chemist Lutz Ackermann with Hansen Family Award
Chemist Lutz Ackermann Honored With Bayer Foundation’s Hansen Family Award; Four Young Researchers Receive Early Excellence in Science Awards Georg-August University Göttingen chemist Prof. Dr. Lutz Ackermann has been awarded…
CVS Health Expands Access to Affordable Fertility Care
CVS Health Expands Access to Affordable Fertility Treatments Nationwide CVS Health (NYSE: CVS) has announced a major step toward improving access to fertility care and making fertility treatments more affordable…
Novartis’ Fabhalta® Meets Phase III Goal, Slows Kidney Decline in IgA Nephropathy
Novartis’ Fabhalta® (Iptacopan) Achieves Positive Phase III Results, Marking Major Progress in Slowing Kidney Function Decline in Patients With IgA Nephropathy Novartis announced encouraging final results from its pivotal Phase…
Roche Showcases Breakthroughs in Sequencing by Expansion and Sets New World Record at ASHG 2025
Roche Showcases Breakthrough Sequencing by Expansion (SBX) Technology and Sets New GUINNESS WORLD RECORD™ at ASHG 2025 Roche (SIX: RO, ROG; OTCQX: RHHBY) unveiled a series of groundbreaking advancements in…
Merck’s KEYNOTE-B96 Trial Meets OS Goal in Platinum-Resistant Ovarian Cancer
Merck’s Phase 3 KEYNOTE-B96 Trial Achieves Key Milestone in Platinum-Resistant Ovarian Cancer, Demonstrating Survival Benefit in All-Comer Population Merck (NYSE: MRK), known as MSD outside of the United States and…
Pulse Biosciences Announces Nasdaq Inducement Grants
Pulse Biosciences Grants Inducement Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4) Pulse Biosciences, Inc. (Nasdaq: PLSE), a bioelectric medicine company pioneering applications of its proprietary Nanosecond Pulsed Field…
Digitail and CDMV Partner to Enhance Veterinary Care
Digitail and CDMV Partner to Streamline Veterinary Operations and Improve Patient Care Across Canada Digitail, the industry’s leading AI-native veterinary practice information management system (PIMS), has announced a strategic integration…
bioAffinity Technologies Restores Nasdaq Compliance
bioAffinity Technologies Restores Nasdaq Compliance, Strengthening Path Toward Long-Term Growth bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company dedicated to advancing early-stage cancer diagnostics, announced that it has successfully…